# Digital Twins in Healthcare: Methodological Challenges and Opportunities

**Authors:** Charles Meijer, Hae-Won Uh, Said el Bouhaddani

PMC · DOI: 10.3390/jpm13101522 · Journal of Personalized Medicine · 2023-10-23

## TL;DR

Digital twin technology in healthcare offers personalized patient monitoring and treatment strategies, but faces challenges in data integration and standardization.

## Contribution

This review provides an in-depth analysis of data sources and methodologies for constructing digital twins in healthcare.

## Key findings

- Digital twins can aid in drug effect prediction and novel treatment target discovery.
- Integration of multi-omics data and imaging presents significant challenges.
- Advancements in data collection and computational modeling are crucial for improving digital twin systems.

## Abstract

One of the most promising advancements in healthcare is the application of digital twin technology, offering valuable applications in monitoring, diagnosis, and development of treatment strategies tailored to individual patients. Furthermore, digital twins could also be helpful in finding novel treatment targets and predicting the effects of drugs and other chemical substances in development. In this review article, we consider digital twins as virtual counterparts of real human patients. The primary aim of this narrative review is to give an in-depth look into the various data sources and methodologies that contribute to the construction of digital twins across several healthcare domains. Each data source, including blood glucose levels, heart MRI and CT scans, cardiac electrophysiology, written reports, and multi-omics data, comes with different challenges regarding standardization, integration, and interpretation. We showcase how various datasets and methods are used to overcome these obstacles and generate a digital twin. While digital twin technology has seen significant progress, there are still hurdles in the way to achieving a fully comprehensive patient digital twin. Developments in non-invasive and high-throughput data collection, as well as advancements in modeling and computational power will be crucial to improve digital twin systems. We discuss a few critical developments in light of the current state of digital twin technology. Despite challenges, digital twin research holds great promise for personalized patient care and has the potential to shape the future of healthcare innovation.

## Full-text entities

- **Genes:** INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}, HPS1 (HPS1 biogenesis of lysosomal organelles complex 3 subunit 1) [NCBI Gene 3257] {aka BLOC3S1, HPS}, GCG (glucagon) [NCBI Gene 2641] {aka GLP-1, GLP1, GLP2, GRPP}
- **Diseases:** hypoglycemia (MESH:D007003), injury to people or property (MESH:C000719191), metastases (MESH:D009362), diabetes (MESH:D003920), cardiovascular diseases (MESH:D002318), CDT (MESH:D004200), cancer (MESH:D009369), COVID (MESH:D000086382), Cardiac Digital (MESH:D006331)
- **Chemicals:** Blood glucose (MESH:D001786), oxygen (MESH:D010100), Glucose (MESH:D005947), SDS (MESH:D012967)
- **Species:** Gammacoronavirus (genus) [taxon 694013], Homo sapiens (human, species) [taxon 9606], Severe acute respiratory syndrome coronavirus 2 (no rank) [taxon 2697049], Saccharomyces cerevisiae (baker's yeast, species) [taxon 4932], Cercopithecidae (monkey, family) [taxon 9527]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC10608065/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC10608065/full.md

## References

34 references — full list in the complete paper: https://tomesphere.com/paper/PMC10608065/full.md

---
Source: https://tomesphere.com/paper/PMC10608065